FDA sees 50% increase in Form 2253 submissions

Share this article:
There has been a 50% increase to 61,000 in FDA Form 2253s submitted with promotional pieces during the past four years to the FDA’s Division of Drug Marketing, Advertising and Communications (DDMAC). Of these, 43,000 pieces were professional ads, and almost 11,000 were DTC.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in News

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.